PALI•benzinga•
Palisade Bio shares are trading higher after the company announced the presentation of data from two studios showing ex vivo bioactivation of PALI-2108 in the treatment of Ulcerative Colitis.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga